SBI Securities’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$296K Sell
3,225
-31
-1% -$2.71K 0.01% 547
2026
Q1
$278K Sell
3,256
-210
-6% -$18.7K 0.01% 542
2025
Q4
$274K Sell
3,466
-140
-4% -$11K 0.01% 536
2025
Q3
$288K Buy
3,606
+240
+7% +$20.5K 0.01% 528
2025
Q2
$306K Buy
3,366
+185
+6% +$16.9K 0.01% 470
2025
Q1
$298K Sell
3,181
-161
-5% -$14.4K 0.01% 435
2024
Q4
$304K Buy
+3,342
New +$319K 0.01% 439

Other funds holding CL

SBI Securities's CL Position: Q2 2026 in Review

SBI Securities reduced its Colgate-Palmolive (CL) stake by 0.95% in Q2 2026, selling an estimated $2.71K and leaving 3,225 shares worth $296K. The position accounts for 0.01% of the portfolio, ranked #547.

SBI Securities first reported a position in CL in Q4 2024 and has held it in 7 quarters since. The position peaked at $306K in Q2 2025. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • SBI Securities held 3,225 shares of Colgate-Palmolive worth $296K as of Q2 2026.
  • SBI Securities sold 31 Colgate-Palmolive shares in Q2 2026, an estimated $2.71K.
  • Colgate-Palmolive made up 0.01% of SBI Securities's portfolio in Q2 2026, its #547 holding.
  • SBI Securities first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Colgate-Palmolive position peaked at $306K in Q2 2025.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.